查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1818190

CT-NG 检测市场报告：2031 年趋势、预测与竞争分析

CT-NG Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球CT-NG检测市场前景光明，诊断实验室和医院诊所都蕴藏着巨大的机会。预计2025年至2031年，全球CT-NG检测市场的复合年增长率将达到8.2%。该市场的主要驱动力在于市场扩张和诊断工具技术活性化的投资和资金筹措的增加。

  • 根据 Lucintel 的预测，由于实验室测试具有更高的敏感性和特异性，预计在预测期内各类实验室测试将出现更高的增长。
  • 从应用角度来看，由于 PoC 和自我测试技术的日益普及，诊断实验室预计将实现高速成长。
  • 按地区划分，预计北美将在预测期内实现最高成长。

CT-NG检测市场新趋势

受技术进步、意识提升和医疗保健重点变化等新兴趋势的影响，CT-NG 检测市场正在不断发展。这些趋势正在改变 CT-NG 检测的执行方式，使其更快、更准确，并惠及更广泛的人群。以下是塑造 CT-NG 检测市场未来的五个关键趋势。

  • 就地检验(POCT) 的普及率不断提升：就地检验(CT-NG) 检测市场的一大趋势。 POCT 能够提供快速且准确的结果，不仅方便快捷，还具备在传统医疗机构之外进行个人检测的潜力。这一趋势将对农村和服务欠缺地区产生特别显着的影响，因为这些地区缺乏实验室检测。即时检测可以缩短週转时间，提高检测频率，并提高早期发现和治疗的可能性。
  • 家用检测套组的成长：受消费者对隐私、便利和健康控制的需求推动，家用检测套组在性传染感染（CT-NG）检测市场迅速普及。这些套件允许个人采集检体并将其送至实验室进行分析，这使得性传染感染检测更加便捷，尤其是在医疗机构资源有限的社区。随着诊断技术的进步，家用检测预计将得到推广，为诊所检测提供可靠且经济高效的替代方案。
  • 更精准的分子诊断：分子诊断，尤其是核酸增幅检查(NAAT)，正成为衣原体感染 (CT-NG) 检测的黄金标准。这些检测具有高灵敏度和特异性，是准确检测披衣菌感染衣原体和淋病奈瑟菌的理想选择。分子诊断因其准确性高、能够检测低细菌载量以及兼容多种检体类型（包括尿液和自采样检体）而在全球范围内日益普及。
  • 与数位健康平台的整合：性传染感染阴性（CT-NG）检测与数位健康平台的整合是另一个日益增长的趋势。行动应用程式和线上平台使个人能够预约性传播感染检测、获取检测结果并接受远端医疗咨询。这种数位化转变预计将提高检测频率，并透过为个人提供更方便的检测和护理途径来改善公共卫生结果。这一趋势对于青少年和年轻人等高危险群尤其重要。
  • 预防性医疗保健日益受到重视：预防性医疗保健在新生儿破伤风 (CT-NG) 检测市场中发展势头强劲。各国政府和医疗保健机构正将性传染感染 (STI)筛检作为常规体检的一部分，尤其重视性活跃族群。定期筛检以及安全性行为教育被视为降低性传染感染发生率和促进早期诊断的关键策略。这种预防性方法正在重塑市场，导致对价格合理且易于获取的新生儿破伤风 (CT-NG) 检测解决方案的需求日益增长。

就地检验、家用套件以及分子诊断兴起等趋势的推动，性传染感染（CT-NG）检测市场正经历重大变革时期。这些发展正在重塑性传染感染（STI）检测的执行方式，使其更易于取得、更准确、更便捷，惠及更广泛的人群。

CT-NG检测市场的最新趋势

近期，在诊断创新、认知度提升以及对便利检测解决方案需求不断增长的推动下，性传染感染 (CT-NG) 检测市场呈现出显着趋势。以下是塑造性传染感染 (CT-NG) 检测市场的五大关键发展，反映了性传染感染 (STI) 检测在准确性、速度和患者可近性方面的进步。

  • FDA核准快速检测套组：披衣菌感染（CT-NG）检测市场的最新进展是 FDA核准了披衣菌感染和淋病快速诊断套件。这些套件只需传统实验室检测所需时间的一小部分即可获得结果，为患者和医疗保健提供者提供了便捷的解决方案。这项创新有望显着改善性传染感染（STI）的筛检和治疗，尤其是在急诊、诊所和社区健康机构。
  • 分子诊断的扩展：核酸增幅检查(NAAT) 等分子诊断方法的广泛应用提高了性传播感染 (CT-NG) 检测的敏感度和特异性。这些检测可以检测到较低的细菌量，即使在无症状个体中也能提供更准确的结果。许多医疗保健系统，包括美国、德国和日本的医疗保健系统，由于其可靠性，正逐渐将分子检测作为性传染感染 (STI)筛检的标准方法。
  • 自测检测套组的开发：CT-NG 的自测检测套组已成为市场变革者，让个人能够在自己家中私密地检测性传染感染。这些套件允许使用者在家中采集样本并将其送至实验室进行分析。这项创新增加了人们获得检测的机会，尤其是在传统医疗基础设施有限的地区。自测检测套组的便利性和隐私性推动了其广泛应用。
  • 与远端医疗的日益融合：远端医疗已成为性传播感染（CT-NG）检测的重要推动力，使患者能够远距接受性传播感染（STI）检测和咨询服务。将检测与远端医疗服务结合的数位医疗平台正变得越来越普遍，为使用者提供虚拟咨询、检测预约和结果解读服务。这一发展尤其有利于服务于服务匮乏的人群，改善医疗保健的可近性，并提升患者的便利性。
  • 政府支持的性传染感染检测宣传活动：世界各国政府正在加强推广性传染感染检测，尤其是在年轻人和高危险群中。美国、印度和中国等国的公共卫生措施提高了人们对定期检测和早期发现重要性的认识。政府对性传染感染筛检计画和教育宣传活动的资助，促进了CT-NG检测的广泛应用。

这些发展凸显了CT-NG检测市场的持续演变，其特点是检测技术的创新、可近性的提高以及公众健康意识的提升。随着这些进步持续塑造市场，CT-NG检测的未来将更加光明，更具包容性。

目录

第一章执行摘要

第二章 市场概况

  • 背景和分类
  • 供应链

第三章：市场趋势及预测分析

  • 宏观经济趋势与预测
  • 产业驱动力与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4.按类型分類的全球 CT-NG 检测市场

  • 概述
  • 按类型进行吸引力分析
  • 实验室检验：趋势与预测（2019-2031）
  • PoC 测试：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

第五章全球 CT-NG 测试市场（按应用）

  • 概述
  • 按用途进行吸引力分析
  • 诊断实验室：趋势与预测（2019-2031）
  • 医院与诊所：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

第六章 区域分析

  • 概述
  • 区域 CT-NG 测试市场

7.北美CT-NG检测市场

  • 概述
  • 美国CT-NG检测市场
  • 墨西哥的CT-NG检测市场
  • 加拿大 CT-NG 检测市场

八、欧洲CT-NG检测市场

  • 概述
  • 德国CT-NG检测市场
  • 法国CT-NG检测市场
  • 西班牙CT-NG检测市场
  • 义大利CT-NG检测市场
  • 英国CT-NG 检测市场

9.亚太CT-NG检测市场

  • 概述
  • 日本CT-NG检测市场
  • 印度CT-NG检测市场
  • 中国CT-NG检测市场
  • 韩国CT-NG检查市场
  • 印尼CT-NG检测市场

第十章世界其他地区 CT-NG 测试市场

  • 概述
  • 中东CT-NG检测市场
  • 南美洲CT-NG检查市场
  • 非洲CT-NG检测市场

第11章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 按应用分類的成长机会
  • 全球 CT-NG 检测市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 合併、收购、协议、合作和合资企业

第十三章 价值链主要企业的公司简介

  • 竞争分析
  • Roche
  • Hologic
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Danaher

第十四章 附录

  • 图表目录
  • 表格一览
  • 调查方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于我们
  • 联络处

The future of the global CT-NG testing market looks promising with opportunities in the diagnostic laboratories and hospitals & clinics markets. The global CT-NG testing market is expected to grow with a CAGR of 8.2% from 2025 to 2031. The major drivers for this market are the boosting investments & funding to fuel market expansion. and the technological advancements in diagnostic tools.

  • Lucintel forecasts that, within the type category, lab tests is expected to witness higher growth over the forecast period due to lab tests are equipped with higher sensitivity and specificity.
  • Within the application category, diagnostic laboratories is expected to witness the higher growth due to growing adoption of PoC and self-testing technologies.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the CT-NG Testing Market

The CT-NG testing market is evolving with emerging trends driven by technological advancements, increasing awareness, and shifting healthcare priorities. These trends are transforming the way CT-NG testing is conducted, making it faster, more accurate, and accessible to a broader population. Below are five key trends shaping the future of the CT-NG testing market.

  • Increased Adoption of Point-of-Care Testing (POCT): Point-of-care testing is becoming a significant trend in the CT-NG testing market. With rapid and accurate results, POCT offers convenience and the potential to test individuals outside of traditional healthcare settings. This trend is particularly impactful in rural or underserved areas, where access to lab-based testing is limited. The ability to test on-site reduces turnaround times, increases testing frequency, and improves the likelihood of early detection and treatment.
  • Growth of At-Home Testing Kits: At-home testing kits are rapidly gaining popularity in the CT-NG testing market, driven by consumer demand for privacy, convenience, and control over their health. These kits, which allow individuals to collect samples and send them to labs for analysis, make STI testing more accessible, especially in communities with limited access to healthcare facilities. As diagnostic technologies improve, at-home testing is expected to expand, offering a reliable and cost-effective alternative to in-clinic testing.
  • Molecular Diagnostics for Higher Accuracy: Molecular diagnostics, particularly NAAT (Nucleic Acid Amplification Test), are becoming the gold standard for CT-NG testing. These tests offer high sensitivity and specificity, making them ideal for accurate detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Molecular diagnostics are being increasingly adopted globally due to their accuracy, ability to detect low bacterial loads, and suitability for a range of sample types, such as urine or self-collected samples.
  • Integration with Digital Health Platforms: The integration of CT-NG testing with digital health platforms is another growing trend. Mobile apps and online platforms are enabling individuals to manage their STI testing schedules, access results, and receive telehealth consultations. This digital shift is expected to drive more frequent testing and improve public health outcomes by providing individuals with easier access to testing and care. The trend is particularly relevant in high-risk populations, such as adolescents and young adults.
  • Increased Focus on Preventative Healthcare: Preventative healthcare is gaining momentum in the CT-NG testing market. Governments and healthcare providers are placing more emphasis on STI screening as part of routine health checkups, particularly for sexually active individuals. Regular screening, along with education on safe sexual practices, is seen as a key strategy for reducing the incidence of STIs and promoting early diagnosis. This preventative approach is reshaping the market, leading to increased demand for affordable and accessible CT-NG testing solutions.

The CT-NG testing market is undergoing significant transformations, driven by trends such as the rise of point-of-care testing, at-home kits, and molecular diagnostics. These developments are reshaping how STI testing is conducted, improving accessibility, accuracy, and convenience for a broader population.

Recent Developments in the CT-NG Testing Market

The CT-NG testing market has experienced significant developments in recent years, driven by innovations in diagnostic technologies, increased awareness, and growing demand for accessible testing solutions. Below are five key developments shaping the CT-NG testing landscape, which reflect advancements in accuracy, speed, and patient access to STI testing.

  • FDA Approval of Rapid Testing Kits: Recent developments in the CT-NG testing market have seen the FDA's approval of rapid diagnostic kits for Chlamydia and Gonorrhea. These kits provide results in a fraction of the time required for traditional laboratory tests, offering a convenient solution for both patients and healthcare providers. This innovation has the potential to significantly improve STI screening and treatment, particularly in emergency departments, clinics, and community health settings.
  • Expansion of Molecular Diagnostics: The widespread adoption of molecular diagnostics, such as NAAT (Nucleic Acid Amplification Tests), has improved the sensitivity and specificity of CT-NG testing. These tests can detect lower bacterial loads and offer more accurate results, even in asymptomatic individuals. Many healthcare systems, including those in the U.S., Germany, and Japan, are transitioning to molecular testing as the standard method for STI screening due to its reliability.
  • Development of Self-Testing Kits: Self-testing kits for CT-NG have emerged as a game-changer in the market, providing individuals with the ability to test for STIs in the privacy of their own homes. These kits allow users to collect samples at home, which are then sent to a lab for analysis. This innovation has increased access to testing, especially in areas where traditional healthcare infrastructure is limited. The convenience and privacy of self-testing kits are driving their adoption.
  • Increased Integration with Telemedicine: Telemedicine has become a key enabler of CT-NG testing, allowing patients to access STI testing and counseling services remotely. Digital health platforms that integrate testing with telemedicine services are becoming more widespread, providing users with virtual consultations, test ordering, and result interpretation. This development is particularly beneficial in reaching underserved populations, improving access to healthcare, and enhancing patient convenience.
  • Government-Backed STI Testing Campaigns: Governments worldwide have increased their efforts to promote STI testing, with a particular focus on young adults and high-risk populations. Public health initiatives in countries like the U.S., India, and China have led to greater awareness of the importance of regular testing and early detection. Government funding for STI screening programs, as well as educational campaigns, are contributing to the widespread adoption of CT-NG testing.

These developments highlight the ongoing progress in the CT-NG testing market, characterized by innovations in testing technologies, increased accessibility, and a greater focus on public health awareness. As these advancements continue to shape the market, the future of CT-NG testing looks brighter and more inclusive.

Strategic Growth Opportunities in the CT-NG Testing Market

The CT-NG testing market offers various growth opportunities across key applications, particularly in healthcare diagnostics, public health programs, and point-of-care settings. As demand for STI testing rises globally, companies can leverage new technologies and expanding market access to capture growth. Below are five strategic growth opportunities for CT-NG testing in different applications?

  • Point-of-Care Testing in Rural Areas: Expanding point-of-care testing solutions in rural and underserved areas represents a significant growth opportunity. By providing quick and accurate results outside traditional lab settings, these solutions can increase accessibility for populations with limited healthcare access. This would improve STI detection and treatment, particularly in remote regions of developing countries.
  • Adoption of At-Home Self-Testing Kits: The increasing popularity of at-home self-testing kits offers a lucrative growth opportunity in the CT-NG testing market. With privacy and convenience being significant concerns, these kits allow users to collect samples in their own homes and send them to labs for analysis. As the demand for at-home diagnostics rises, the market for these self-testing kits is expected to expand.
  • Integration with Telehealth and Digital Platforms: Telehealth has become a growing trend in healthcare, and integrating CT-NG testing with telemedicine platforms can create growth opportunities. This model offers virtual consultations, remote testing orders, and accessible results, making STI testing more convenient. The integration of digital health tools is expected to drive testing adoption rates and make healthcare services more accessible to global populations.
  • Government-Funded Public Health Initiatives: Governments worldwide are investing in STI testing and prevention programs. Public health campaigns, particularly in countries like the U.S., China, and India, represent a growth opportunity for CT-NG testing providers. By partnering with governments, companies can expand testing accessibility and raise awareness of the importance of early detection.
  • Expansion into Emerging Markets: Emerging markets, particularly in Africa and Asia, present significant growth opportunities for CT-NG testing. Rising awareness of STIs, combined with the adoption of cost-effective, mobile-based diagnostics, creates a vast market for CT-NG testing. Companies entering these markets can play a key role in improving sexual health awareness and offering essential testing services to underserved populations.

The CT-NG testing market offers several strategic growth opportunities, including expanding access through point-of-care and self-testing kits, leveraging telehealth platforms, and tapping into emerging markets. These opportunities will be crucial in driving the growth of the market and improving global STI testing rates.

CT-NG Testing Market Driver and Challenges

The CT-NG testing market is influenced by a mix of technological, economic, and regulatory drivers and challenges. Key drivers, such as advances in diagnostics and increasing public health initiatives, foster market growth, while challenges like cost and regulatory hurdles pose obstacles to wider adoption. Below are the primary drivers and challenges impacting the market.

The factors responsible for driving the CT-NG testing market include:

1. Advancements in Diagnostic Technology: The development of more accurate and faster diagnostic tools, such as NAAT, is a key driver in the CT-NG testing market. These technologies offer higher sensitivity and specificity, making it easier to detect infections and improve treatment outcomes.

2. Growing Public Health Awareness: Rising awareness of sexually transmitted infections and the importance of early detection is increasing the demand for CT-NG testing. Public health campaigns and educational programs are encouraging more people to get tested regularly.

3. Rising Demand for Convenient Testing Options: Consumers are increasingly seeking more convenient testing options, such as point-of-care testing and at-home self-testing kits. These options provide faster results and greater accessibility, driving demand for innovative diagnostic solutions.

4. Government Support for STI Prevention: Governments across the world are promoting STI testing as part of national public health strategies. Funding for STI prevention programs, as well as subsidies for diagnostic tests, is expanding access to testing and driving market growth.

5. Growing Incidence of STIs: The increasing incidence of Chlamydia and Gonorrhea infections globally is driving the demand for CT-NG testing. As more individuals are diagnosed with STIs, the need for regular and accessible testing becomes even more pressing.

Challenges in the CT-NG testing market are:

1. High Cost of Testing: The cost of advanced diagnostic tests remains a significant challenge, particularly in low-income regions. The high price of testing equipment and reagents can limit access to CT-NG testing, particularly in developing countries.

2. Limited Access in Rural Areas: Despite advances in testing technologies, access to CT-NG testing remains limited in rural and remote areas, where healthcare infrastructure is underdeveloped. This disparity in access hinders the widespread adoption of testing.

3. Regulatory Barriers: Stringent regulatory standards for testing products can delay market entry for new diagnostic technologies. Regulatory approval processes vary by region, which can create barriers for companies trying to expand into new markets.

The CT-NG testing market is driven by advancements in diagnostic technologies, rising awareness, and government initiatives, but faces challenges related to cost, access, and regulation. These factors collectively shape the market's growth and will continue to influence its development in the coming years.

List of CT-NG Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies CT-NG testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the CT-NG testing companies profiled in this report include-

  • Roche
  • Hologic
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Danaher

CT-NG Testing Market by Segment

The study includes a forecast for the global CT-NG testing market by type, application, and region.

CT-NG Testing Market by Type [Value from 2019 to 2031]:

  • Lab Tests
  • PoC Tests
  • Others

CT-NG Testing Market by Application [Value from 2019 to 2031]:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

CT-NG Testing Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the CT-NG Testing Market

The CT-NG (Chlamydia trachomatis and Neisseria gonorrhoeae) testing market has seen significant advancements, driven by technological innovations, increasing awareness of sexually transmitted infections (STIs), and growing demand for accessible, accurate diagnostics. In particular, rapid molecular diagnostic tests, such as nucleic acid amplification tests (NAATs), have led to improved accuracy and faster results. As healthcare systems in various countries, such as the United States, China, Germany, India, and Japan, continue to focus on STI control, the CT-NG testing market is evolving to meet these demands and align with changing healthcare priorities. Below are recent developments in key markets.

  • United States: In the U.S., CT-NG testing has become increasingly accessible due to the introduction of more user-friendly and rapid diagnostic tests. The U.S. Food and Drug Administration (FDA) has approved several new tests that offer higher sensitivity and specificity. There's a growing emphasis on point-of-care testing (POCT) and at-home testing kits, reflecting a shift toward convenient and cost-effective options. Furthermore, public health campaigns and government initiatives focused on increasing STI awareness and regular testing have contributed to the rise in demand for CT-NG testing, especially in sexually active populations and high-risk groups.
  • China: China has seen a rise in the adoption of CT-NG testing in both urban and rural areas, driven by increased public awareness of STIs and the need for more efficient diagnostic solutions. The government's healthcare reforms have led to the wider availability of testing in clinics and hospitals, particularly in regions with higher STI rates. Technological advancements in molecular diagnostics, such as NAAT, have further accelerated the market's growth. Additionally, China's large population and growing focus on public health have driven the development of more affordable and accessible CT-NG testing solutions.
  • Germany: Germany has implemented widespread CT-NG testing protocols as part of its national public health strategy. The country has focused on integrating rapid molecular diagnostic tests in routine sexual health screenings. Germany's healthcare system is well-equipped to offer comprehensive STI screening, and the use of NAATs has become a standard practice in most medical facilities. With a strong focus on STI prevention and treatment, the market is expanding, with more efficient, accurate, and faster diagnostic tools becoming available. Germany's proactive healthcare approach has contributed to increased adoption rates and more regular testing among the general population.
  • India: In India, the CT-NG testing market is growing, driven by rising awareness of STIs, particularly in urban areas. Government-backed initiatives to increase STI testing, along with the expansion of private healthcare facilities offering STI screenings, have fueled the market's growth. However, the availability and affordability of testing remain significant challenges in rural areas, where public health infrastructure is limited. In response, there have been advancements in mobile health clinics and affordable diagnostic solutions to expand access. Technological innovations, such as mobile-based testing solutions, are also gaining traction as potential game-changers in the market.
  • Japan: Japan has seen an increased focus on STI prevention and testing, with a significant rise in demand for CT-NG testing in clinics and hospitals. The integration of advanced diagnostic technologies, including PCR-based tests and NAATs, has enabled faster and more accurate results. Japan's well-developed healthcare system supports the widespread availability of testing, particularly in metropolitan areas. Additionally, there is a growing trend towards self-testing kits and increased awareness of sexual health, contributing to more widespread adoption of CT-NG testing across the population.

Features of the Global CT-NG Testing Market

  • Market Size Estimates: Ct-ng testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Ct-ng testing market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Ct-ng testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, application, and regions for the CT-NG testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the CT-NG testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the CT-NG testing market by type (lab tests, PoC tests, and others), application (diagnostic laboratories, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global CT-NG Testing Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Lab Tests: Trends and Forecast (2019-2031)
  • 4.4 PoC Tests: Trends and Forecast (2019-2031)
  • 4.5 Others: Trends and Forecast (2019-2031)

5. Global CT-NG Testing Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Diagnostic Laboratories: Trends and Forecast (2019-2031)
  • 5.4 Hospitals & Clinics: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global CT-NG Testing Market by Region

7. North American CT-NG Testing Market

  • 7.1 Overview
  • 7.4 United States CT-NG Testing Market
  • 7.5 Mexican CT-NG Testing Market
  • 7.6 Canadian CT-NG Testing Market

8. European CT-NG Testing Market

  • 8.1 Overview
  • 8.4 German CT-NG Testing Market
  • 8.5 French CT-NG Testing Market
  • 8.6 Spanish CT-NG Testing Market
  • 8.7 Italian CT-NG Testing Market
  • 8.8 United Kingdom CT-NG Testing Market

9. APAC CT-NG Testing Market

  • 9.1 Overview
  • 9.4 Japanese CT-NG Testing Market
  • 9.5 Indian CT-NG Testing Market
  • 9.6 Chinese CT-NG Testing Market
  • 9.7 South Korean CT-NG Testing Market
  • 9.8 Indonesian CT-NG Testing Market

10. ROW CT-NG Testing Market

  • 10.1 Overview
  • 10.4 Middle Eastern CT-NG Testing Market
  • 10.5 South American CT-NG Testing Market
  • 10.6 African CT-NG Testing Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global CT-NG Testing Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Roche
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Hologic
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Thermo Fisher Scientific
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Abbott Laboratories
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Bio-Rad Laboratories
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Siemens Healthineers
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Danaher
    • Company Overview
    • CT-NG Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global CT-NG Testing Market
  • Figure 2.1: Usage of CT-NG Testing Market
  • Figure 2.2: Classification of the Global CT-NG Testing Market
  • Figure 2.3: Supply Chain of the Global CT-NG Testing Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the CT-NG Testing Market
  • Figure 4.1: Global CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global CT-NG Testing Market ($B) by Type
  • Figure 4.3: Forecast for the Global CT-NG Testing Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Lab Tests in the Global CT-NG Testing Market (2019-2031)
  • Figure 4.5: Trends and Forecast for PoC Tests in the Global CT-NG Testing Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Others in the Global CT-NG Testing Market (2019-2031)
  • Figure 5.1: Global CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global CT-NG Testing Market ($B) by Application
  • Figure 5.3: Forecast for the Global CT-NG Testing Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Diagnostic Laboratories in the Global CT-NG Testing Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Hospitals & Clinics in the Global CT-NG Testing Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global CT-NG Testing Market (2019-2031)
  • Figure 6.1: Trends of the Global CT-NG Testing Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global CT-NG Testing Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American CT-NG Testing Market (2019-2031)
  • Figure 7.2: North American CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 7.5: North American CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States CT-NG Testing Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican CT-NG Testing Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European CT-NG Testing Market (2019-2031)
  • Figure 8.2: European CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 8.5: European CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian CT-NG Testing Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC CT-NG Testing Market (2019-2031)
  • Figure 9.2: APAC CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean CT-NG Testing Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian CT-NG Testing Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW CT-NG Testing Market (2019-2031)
  • Figure 10.2: ROW CT-NG Testing Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW CT-NG Testing Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW CT-NG Testing Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW CT-NG Testing Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW CT-NG Testing Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW CT-NG Testing Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern CT-NG Testing Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American CT-NG Testing Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African CT-NG Testing Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global CT-NG Testing Market
  • Figure 11.2: Market Share (%) of Top Players in the Global CT-NG Testing Market (2024)
  • Figure 12.1: Growth Opportunities for the Global CT-NG Testing Market by Type
  • Figure 12.2: Growth Opportunities for the Global CT-NG Testing Market by Application
  • Figure 12.3: Growth Opportunities for the Global CT-NG Testing Market by Region
  • Figure 12.4: Emerging Trends in the Global CT-NG Testing Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the CT-NG Testing Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the CT-NG Testing Market by Region
  • Table 1.3: Global CT-NG Testing Market Parameters and Attributes
  • Table 3.1: Trends of the Global CT-NG Testing Market (2019-2024)
  • Table 3.2: Forecast for the Global CT-NG Testing Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global CT-NG Testing Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global CT-NG Testing Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global CT-NG Testing Market (2025-2031)
  • Table 4.4: Trends of Lab Tests in the Global CT-NG Testing Market (2019-2024)
  • Table 4.5: Forecast for Lab Tests in the Global CT-NG Testing Market (2025-2031)
  • Table 4.6: Trends of PoC Tests in the Global CT-NG Testing Market (2019-2024)
  • Table 4.7: Forecast for PoC Tests in the Global CT-NG Testing Market (2025-2031)
  • Table 4.8: Trends of Others in the Global CT-NG Testing Market (2019-2024)
  • Table 4.9: Forecast for Others in the Global CT-NG Testing Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global CT-NG Testing Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global CT-NG Testing Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global CT-NG Testing Market (2025-2031)
  • Table 5.4: Trends of Diagnostic Laboratories in the Global CT-NG Testing Market (2019-2024)
  • Table 5.5: Forecast for Diagnostic Laboratories in the Global CT-NG Testing Market (2025-2031)
  • Table 5.6: Trends of Hospitals & Clinics in the Global CT-NG Testing Market (2019-2024)
  • Table 5.7: Forecast for Hospitals & Clinics in the Global CT-NG Testing Market (2025-2031)
  • Table 5.8: Trends of Others in the Global CT-NG Testing Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global CT-NG Testing Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global CT-NG Testing Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global CT-NG Testing Market (2025-2031)
  • Table 7.1: Trends of the North American CT-NG Testing Market (2019-2024)
  • Table 7.2: Forecast for the North American CT-NG Testing Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American CT-NG Testing Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American CT-NG Testing Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American CT-NG Testing Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American CT-NG Testing Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States CT-NG Testing Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican CT-NG Testing Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian CT-NG Testing Market (2019-2031)
  • Table 8.1: Trends of the European CT-NG Testing Market (2019-2024)
  • Table 8.2: Forecast for the European CT-NG Testing Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European CT-NG Testing Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European CT-NG Testing Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European CT-NG Testing Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European CT-NG Testing Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German CT-NG Testing Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French CT-NG Testing Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish CT-NG Testing Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian CT-NG Testing Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom CT-NG Testing Market (2019-2031)
  • Table 9.1: Trends of the APAC CT-NG Testing Market (2019-2024)
  • Table 9.2: Forecast for the APAC CT-NG Testing Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC CT-NG Testing Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC CT-NG Testing Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC CT-NG Testing Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC CT-NG Testing Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese CT-NG Testing Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian CT-NG Testing Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese CT-NG Testing Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean CT-NG Testing Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian CT-NG Testing Market (2019-2031)
  • Table 10.1: Trends of the ROW CT-NG Testing Market (2019-2024)
  • Table 10.2: Forecast for the ROW CT-NG Testing Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW CT-NG Testing Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW CT-NG Testing Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW CT-NG Testing Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW CT-NG Testing Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern CT-NG Testing Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American CT-NG Testing Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African CT-NG Testing Market (2019-2031)
  • Table 11.1: Product Mapping of CT-NG Testing Suppliers Based on Segments
  • Table 11.2: Operational Integration of CT-NG Testing Manufacturers
  • Table 11.3: Rankings of Suppliers Based on CT-NG Testing Revenue
  • Table 12.1: New Product Launches by Major CT-NG Testing Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global CT-NG Testing Market